Neutralizing the MERS coronavirus threat.
Level V
Where this comes from
- Record sourced from PubMed, PMID 24807556.
- Also identified by DOI 10.1126/scitranslmed.3009132.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Human neutralizing monoclonal antibodies are candidates for prophylactic and therapeutic interventions against Middle East respiratory syndrome coronavirus (MERS-CoV) infection.
Medical subject headings
- Antibodies, Neutralizing
- Coronavirus Infections
- Middle East Respiratory Syndrome Coronavirus